Igradin Tablets 2 mg (Irsozgladin Maleate)

Adult dose

1) Gastric ulcers (Adults) Administer irsogladine maleate 4mg orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer irsogladine maleate 4mg orally in 1∼2 divided doses daily.

This medication should not be used by patients with a genetic disease that prevents the digestion of lactose, as it contains lactose. While taking this medication, side effects such as liver dysfunction, constipation, rash, itching, and diarrhea may occur; therefore, if symptoms arise, consult a physician immediately. Research conducted in Japan and domestically has reported elevated liver enzyme levels and gastrointestinal disturbance symptoms in some patients, so caution is advised. Particularly in the elderly, physical functions may be reduced, so it is recommended to start with a low dose and monitor the condition closely. Women who are pregnant or may become pregnant should only take this medication if the benefits outweigh the risks, and safety during pregnancy is not established. Nursing mothers should avoid this medication if possible, as it may be transmitted through breast milk; if necessary, breastfeeding should be discontinued. Safety in children has not been sufficiently established, so it should be administered to children with caution. This medication should be stored in a safe place out of reach of children, and care should be taken not to change the container as this may alter its quality.

• Abnormal liver function
• elevated ALT (GPT)
• elevated AST (GOT)
• constipation
• rash
• itching
• diarrhea
• elevated ALP
• nausea
• vomiting

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is safe to store at room temperature between 1 degree and 30 degrees.

Appearance

White round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle